WFDC2 and neoplasm: At the time of this study, many challenges in the treatment of OCCC remain: OCCC pathogenesis is unclear; known ovarian cancer-related tumor markers such as CA125, HE4, and others have relatively low sensitivity and specificity for OCC; and no ideal treatment regime for OCCC patients exists.